CellCept 250 Roche (CellCept 250 mg)
Generic Name: mycophenolate mofetil
Pill with imprint CellCept 250 Roche is Orange & Turquoise, Capsule-shape and has been identified as CellCept 250 mg. It is supplied by Roche Laboratories.
CellCept is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. CellCept 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CellCept 250 Roche




CellCept
- Generic Name
- mycophenolate mofetil
- Imprint
- CellCept 250 Roche
- Strength
- 250 mg
- Color
- Orange & Turquoise
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Roche Laboratories
- Inactive Ingredients
-
croscarmellose sodium,
magnesium stearate,
povidone k90,
corn starch,
FD&C Blue No. 2,
ferric oxide yellow,
ferric oxide red,
titanium dioxide,
silicon dioxide,
sodium lauryl sulfate,
shellac,
potassium hydroxide,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00004-0259 | Roche |
49999-0936 (Discontinued) | Lake Erie Medical and Surgical Supply (repackager) |
More about CellCept (mycophenolate mofetil)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (12)
- Drug images
- Compare alternatives
- Pricing & coupons
- Generic availability
- En español
- Drug class: selective immunosuppressants
- FDA approval history
Patient resources
- Drug Information
- Cellcept (Advanced Reading)
- Cellcept Oral (Advanced Reading)
- CellCept (Mycophenolate Mofetil Capsules)
- CellCept (Mycophenolate Mofetil Injection Solution)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.